Company Profile

Microbiotix Inc
Profile last edited on: 3/2/2023      CAGE: 465F8      UEI: SCNKBDM341T1

Business Identifier: Novel small molecule anti-infective drugs
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

One Innovation Drive
Worcester, MA 01605
   (508) 757-2800
Location: Single
Congr. District: 02
County: Worcester

Public Profile

Microbiotix, Inc. is a clinical stage biopharmaceutical company focused on discovery and development of proprietary small molecule drugs target ingserious infectious diseases, including multi-drug resistant pathogens The Company's lead program isMBX-400, a novel, potent nucleoside dual DNA polymerase/kinase inhibitor for the management of cytomegalovirus (CMV) disease in transplant patients. The firm also organizes around R&D of small molecule anti-infective drugs for the treatment of infectious diseases. with a focus on hepatitis C virus (HCV) and cytomegalovirus (CMV). Products include MBX-700 and MBX-701 that are irreversible non-nucleoside inhibitors of the hepatitis C virus polymerase; and MBX-400, a potent nucleoside DNA polymerase inhibitor for the treatment of human cytomegalovirus. The company also engages in clinical R&D of antibacterial and antiviral discovery programs in the areas of filovirus, malaria, gram-negative bacterial infections, multi-drug resistant tuberculosis, and influenza. SInce start-up, Microbiotix has had extensive working relationships with various major players inthe space.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Terry L Bowlin -- President and CEO

  Zachary D Aron

  Marjorie H Barnes

  Arnab Basu

  Jennifer Brooks -- Director of Product Development

  Michelle M Butler

  A Kirk Field

  Richard Gauthier

  Islam Hussein -- Senior Scientist

  Kim Kapteyn

  Gloria Komazin-Meredith

  Bing Li

  Gai Liu

  Stephen Lory

  Tomas Maira-Litran

  Joan C Mecsas

  Donald Taylor Moir -- CSO

  Son Truong Nguyen

  Timothy J Opperman

  Norton P Peet -- Director of Chemistry

  Lijun Rong

  Samanthi Waidyarachchi -- Senior Scientist

  John D Williams

  George E Wright -- Scientific Founder